Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma

ABSTRACT: Objective: This is a prospective, single-arm, phase Ib study to evaluate the safety and efficacy of camrelizumab combined with chemotherapy and apatinib as neoadjuvant therapy for locally advanced thoracic esophageal squamous cell carcinoma (ESCC). Methods: The regimen encompassed 2–4 cyc...

Full description

Bibliographic Details
Main Authors: Zhen Wang, Xiankai Chen, Yong Li, Jianjun Qin, Yuan Fang, Zhaoyang Yang, Yan Fang, Dong Qu, Ruixiang Zhang, Qingfeng Zheng, Xiaozheng Kang, Liyan Xue, Jing Huang, Yin Li, Jie He
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of the National Cancer Center
Subjects:
Esophageal neoplasm
Immunotherapy
Neoadjuvant
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2667005422000199

Internet

http://www.sciencedirect.com/science/article/pii/S2667005422000199

Similar Items